Abstract
Background
The correct identification of the macro-B12 interference (macroforms) is paramount to avoid potential erroneous clinical decisions. Our objectives were to determine whether immunoassays are affected by the presence of macro-B12 and to validate a polyethylene glycol (PEG) precipitation procedure to detect it.
Methods
Sixty-two serum samples obtained from healthy volunteers were analyzed to determine recovery and reference intervals (RIs) following PEG precipitation. Thereafter, 50 serum samples with very high levels of B12 (>1476 pmol/L) were randomly selected to search for macro-B12 interferences. Serum samples obtained from healthy volunteers and related PEG aliquots were analyzed on a Cobas® immunoassay. Patients’ samples were analyzed on both Cobas® and Architect® immunoassays. Finally, samples suspected to contain macro-B12 were analyzed by size-exclusion chromatography (SEC) to confirm the presence of macro-B12.
Results
Recovery and post-PEG RIs determined on a Cobas 8000® in healthy volunteers ranged from 68.3% to 108.4% and from 122.1 to 514.4 pmol/L, respectively. Fifteen samples (30%) were found to show macro-B12 while using the recovery criteria, and nine samples (18%) while using the post-PEG RI. The other immunoassay ran on the Architect i2000® was also affected by the presence of macro-B12. Size-exclusion chromatography studies confirmed the presence of macro-B12 (immunoglobulin-B12 complexes).
Conclusions
The prevalence of macro-B12 in elevated B12 samples is high. We suggest to systematically screen for the presence of macro-B12 with PEG precipitation procedure in samples with elevated B12 levels to avoid potential misdiagnosis or harmful clinical consequences.
Acknowledgments
The authors would like to thank the laboratory technicians, Mrs. Corinne Martin, Mr. Jürgen Lohmann, Mr. Mehdi Mancini, Mr. Matteo Murer, Mrs. Hajar Latrache, Mr. Helder Dos Santos and Mr. Jacques Vanham as well as the laboratories residents, Mrs. Anke Stoefs, Mr. Samy Mzougui and Antoine Mairesse, without whom this work would not have been possible. The authors also acknowledge Roche Diagnostics for performing the size-exclusion chromatography.
Author contributions: All the authors have approved the entire content of the submitted manuscript (and any subsequent revised version) and have accepted responsibility for the entire work.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Rifai N. Tietz textbook of clinical chemistry and molecular diagnostics, 6th ed. St. Louis, MO: Elsevier, 2018.Search in Google Scholar
2. Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med 2013;368:149–60.10.1056/NEJMcp1113996Search in Google Scholar PubMed
3. Bain BJ, Bates I, Laffan M. Dacie and Lewis practical haematology, 11th ed. Edinburgh: Elsevier Churchill Livingstone, 2012.10.1016/B978-0-7020-3408-4.00002-3Search in Google Scholar
4. Ermens AA, Vlasveld LT, Lindemans J. Significance of elevated cobalamin (vitamin B12) levels in blood. Clin Biochem 2003;36:585–90.10.1016/j.clinbiochem.2003.08.004Search in Google Scholar PubMed
5. Arendt JF, Nexo E. Unexpected high plasma cobalamin: proposal for a diagnostic strategy. Clin Chem Lab Med 2013;51:489–96.10.1515/cclm-2012-0545Search in Google Scholar PubMed
6. Chaabouni K, Elleuch A, Turki M, Messedi M, Lahyani A, Jamoussi K, et al. Markedly increased vitamin B12 concentration due to immunological interference. Ann Biol Clin (Paris) 2014;72:129–30.10.1684/abc.2013.0925Search in Google Scholar PubMed
7. Yang DT, Cook RJ. Spurious elevations of vitamin B12 with pernicious anemia. N Engl J Med 2012;366:1742–3.10.1056/NEJMc1201655Search in Google Scholar PubMed
8. Carmel R, Agrawal YP. Failures of cobalamin assays in pernicious anemia. N Engl J Med 2012;367:385–6.10.1056/NEJMc1204070Search in Google Scholar PubMed
9. Saxena S, Carmel R. Racial differences in vitamin B12 levels in the United States. Am J Clin Pathol 1987;88:95–7.10.1093/ajcp/88.1.95Search in Google Scholar PubMed
10. Favresse J, Burlacu MC, Maiter D, Gruson D. Interferences with thyroid function immunoassays: clinical implications and detection algorithm. Endocr Rev 2018;39:830–50.10.1210/er.2018-00119Search in Google Scholar PubMed
11. Clerico A, Belloni L, Carrozza C, Correale M, Dittadi R, Dotti C, et al. A black swan in clinical laboratory practice: the analytical error due to interferences in immunoassay methods. Clin Chem Lab Med 2018;56:397–402.10.1515/cclm-2017-0881Search in Google Scholar PubMed
12. Li D, Radulescu A, Shrestha RT, Root M, Karger AB, Killeen AA, et al. Association of biotin ingestion with performance of hormone and nonhormone assays in healthy adults. J Am Med Assoc 2017;318:1150–60.10.1001/jama.2017.13705Search in Google Scholar
13. Favresse J, Bastin P, Fillée C, Luyckx F, Maiter D, Gruson D. Tracking macroprolactin: use of an optimized polyethylene glycol precipitation method more compatible with the requirements and processes of automated core laboratories. J Appl Lab Med 2017;1:661–7.10.1373/jalm.2016.022632Search in Google Scholar
14. CLSI Document C28-A3c:2008. Defining, establishing and verifying reference intervals in the clinical laboratory, approved guideline, 3rd ed. Wayne, PA: CLSI, 2008;28:61.Search in Google Scholar
15. Geffre A, Concordet D, Braun JP, Trumel C. Reference value advisor: a new freeware set of macroinstructions to calculate reference intervals with Microsoft Excel. Vet Clin Pathol 2011;40:107–12.10.1111/j.1939-165X.2011.00287.xSearch in Google Scholar
16. Solberg HE. International Federation of Clinical Chemistry (IFCC), Scientific Committee, Clinical Section, Expert Panel on Theory of Reference Values, and International Committee for Standardization in Haematology (ICSH), Standing Committee on Reference Values. Approved Recommendation (1986) on the theory of reference values. Part 1. The concept of reference values. J Clin Chem Clin Biochem 1987;25:337–42.10.1016/0009-8981(87)90224-5Search in Google Scholar
17. Ozarda Y. Reference intervals: current status, recent developments and future considerations. Biochem Med (Zagreb) 2016;26:5–16.10.11613/BM.2016.001Search in Google Scholar PubMed PubMed Central
18. Fahie-Wilson M, Halsall D. Polyethylene glycol precipitation: proceed with care. Ann Clin Biochem 2008;45:233–5.10.1258/acb.2008.007262Search in Google Scholar PubMed
19. Jeffery J, Millar H, Mackenzie P, Fahie-Wilson M, Hamilton M, Ayling RM. An IgG complexed form of vitamin B12 is a common cause of elevated serum concentrations. Clin Biochem 2010;43:82–8.10.1016/j.clinbiochem.2009.08.022Search in Google Scholar PubMed
20. Beltran L, Fahie-Wilson MN, McKenna TJ, Kavanagh L, Smith TP. Serum total prolactin and monomeric prolactin reference intervals determined by precipitation with polyethylene glycol: evaluation and validation on common immunoassay platforms. Clin Chem 2008;54:1673–81.10.1373/clinchem.2008.105312Search in Google Scholar PubMed
21. Bowen RA, Drake SK, Vanjani R, Huey ED, Grafman J, Horne 3rd MK. Markedly increased vitamin B12 concentrations attributable to IgG-IgM-vitamin B12 immune complexes. Clin Chem 2006;52:2107–14.10.1373/clinchem.2006.073882Search in Google Scholar PubMed
22. Fahie-Wilson M, Smith TP. Determination of prolactin: the macroprolactin problem. Best Pract Res Clin Endocrinol Metab 2013;27:725–42.10.1016/j.beem.2013.07.002Search in Google Scholar PubMed
23. Carmel R, Vasireddy H, Aurangzeb I, George K. High serum cobalamin levels in the clinical setting – clinical associations and holo-transcobalamin changes. Clin Lab Haematol 2001;23:365–71.10.1046/j.1365-2257.2001.00134.xSearch in Google Scholar PubMed
24. Langabeer SE. Reflective molecular testing for myeloproliferative neoplasms in patients with elevated serum vitamin B12. Ann Clin Biochem 2018;55:717–8.10.1177/0004563218790986Search in Google Scholar PubMed
25. Schilling KA, Wiesgigl M. The Elecsys(R) vitamin B12 assay is not affected by anti-intrinsic factor antibodies. Clin Chem Lab Med 2013;51:e251–2.10.1515/cclm-2013-0359Search in Google Scholar PubMed
26. Ispir E, Serdar MA, Ozgurtas T, Gulbahar O, Akin KO, Yesildal F, et al. Comparison of four automated serum vitamin B12 assays. Clin Chem Lab Med 2015;53:1205–13.10.1515/cclm-2014-0843Search in Google Scholar PubMed
©2020 Walter de Gruyter GmbH, Berlin/Boston
